Recent Posts
- Carvykti found effective at treating multiple myeloma in real world
- New US approval sought for Darzalex Faspro quadruple therapy
- Carvykti lowering risk of death as second-line myeloma therapy: Trial
- FDA approves Sarclisa regimen as first-line treatment for myeloma
- FDA grants Poseida’s CAR T-cell therapy RMAT status for RRMM